The 5′-nucleotidase cytosolic II (NT5C2) variants were reported to be nominally associated with coronary heart disease (CHD) susceptibility in the subgroups of males and with hypertension and diabetes [44]. Here, NT5C2 is linked to coronary artery disorder.